Details

NameSymbolSector
AARTI DRUGS LIMITEDAARTIDRUGSPharmaceuticals
Open
421.5
High
427.9
Low
419.2
Close
421.5
Volume
60740
Exchange
nse
Time
08-Sep-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Aarti Drugs is  
Doji
Estimated Stoploss of Aarti Drugs is ₹  
427.9
Aarti Drugs has a  
Bearishℹ
 pattern. 
Formation of  
Doji
 candle pattern indicates the trend direction of Aarti Drugs is  
Unpredictableℹ
. 

Trend

Aarti Drugs is in  
Sideways trendℹ
. 
Price of Aarti Drugs is  
Upℹ
 by  

2.91

%. 
Target
Buy @ 

359.31

Sell @ 

439.87

Current @ 

421.5

Volume

The trade volumes of Aarti Drugs have become  
Deficientℹ
Though the volume trend for Aarti Drugs appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Aarti Drugs is  

Down

 by  

66.79

% 

Valuation

The current market price of Aarti Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2574cr and total assets worth ₹ 2574cr, the balance sheet of Aarti Drugs is:  
Balancedℹ
. 
Cashflow
Aarti Drugs has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

49.8% i.e. ₹ 244cr earned in operatingℹ
33.47% i.e. ₹ 164cr spent in investingℹ
16.73% i.e. ₹ 82cr spent in financingℹ
0% in otherℹ
Aarti Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

49.93% i.e. ₹ 358cr earned in operatingℹ
31.1% i.e. ₹ 223cr spent in investingℹ
18.97% i.e. ₹ 136cr spent in financingℹ
0% in otherℹ
Income
The income of Aarti Drugs is  

₹ 652cr

 and  

Profit

 is :  

₹ 45cr

(*Sep 2025)

Aarti Drugs Profit is down by:  

15.09

% and Income is Up by:  

10.51

% 

(*Sep 2025)

The income of Aarti Drugs is  

₹ 590cr

 and  

Profit

 is :  

₹ 53cr

(*Jun 2025)

Aarti Drugs Profit is down by:  

14.52

% and Income is Down by:  

12.98

% 

(*Jun 2025)

The income of Aarti Drugs is  

₹ 678cr

 and  

Profit

 is :  

₹ 62cr

(*Mar 2025)

Aarti Drugs Profit is up by:  

67.57

% and Income is Up by:  

19.37

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.